RHEUMATOLOGY MEDICAL SERVICES LIMITEDActive

Company number 12289002Private limited companyIncorporated 2019

Key figures

£55,249+28.9%
Net assets 2023/24
+55.5%
Average annual growth 2019/20–2023/24
020 k40 k60 k2019/202020/212021/222022/232023/24

Like most small UK companies, RHEUMATOLOGY MEDICAL SERVICES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2023/24
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k150 k2019/202020/212021/222022/232023/24
Filed accounts2019/20–2023/24
2019/202020/212021/222022/232023/24
Cash at bank and in hand24,37334,26160,74898,067133,414
Total assets26,49935,20962,276100,057134,671
Total liabilities18,97418,49337,13460,17281,811
Net assets / total equity9,46019,08127,03442,87355,249
Average number of employees02222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: RHEUMATOLOGY MEDICAL SERVICES LIMITED

Company

RHEUMATOLOGY MEDICAL SERVICES LIMITED is a private limited company registered with Companies House under company number 12289002. It was incorporated on 30 Oct 2019. Its status is active. The registered office is in Romford (RM7). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2023/24 (period ending 31 Oct 2024); the company files small company accounts (filleted). Net assets were £55,249, up 28.9% on the previous year. Cash at bank and in hand was £133,414. Total assets were £134,671 and total liabilities £81,811. The company had an average of 2 employees. Figures are available for 5 financial years (2019/20–2023/24).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Oct 2026. The next confirmation statement is due by 12 Nov 2026.